Expertise in
5
conditions

Marc Van Ranst

Immunology And Transplantation, KU Leuven
Leuven, VLG, BE 
Expertise in
5
conditions
Immunology And Transplantation, KU Leuven
Leuven, VLG, BE 

Overview

Marc Van Ranst practices practicing medicine in Leuven, Belgium.

Mr. Van Ranst is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Hantavirus Pulmonary Syndrome, Hantavirus Infection, Severe Acute Respiratory Syndrome (SARS), and Parainfluenza.

He is actively involved in clinical research, co-authoring 202 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Immunology and Transplantation, KU Leuven
Leuven, VLG, Belgium
Other Locations
Gent, VLG, Belgium
Bonheiden, VLG 2820, Belgium
Brussels, BRU, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II Study of a Primary Dose of Investigational RSV Maternal Vaccine, Given Alone or With Boostrix, With a 2nd Dose Investigational RSV Maternal Vaccine
A Phase II Study of a Primary Dose of Investigational RSV Maternal Vaccine, Given Alone or With Boostrix, With a 2nd Dose Investigational RSV Maternal Vaccine
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Biological, Drug
Study Drugs: RSVPreF3, Boostrix-ex-US, Boostrix-US
Study Phase: Phase 2
A Phase 2b, Open-label, Multi-center, Extension Study to Evaluate the Safety and Immunogenicity of a Revaccination Dose of the RSVPreF3 Older Adults (OA) Investigational Vaccine Administered Intramuscularly 18 Months Post-Dose 2 in Adults 60 Years and Older Who Participated in the RSV OA=ADJ-002 Study
A Phase 2b, Open-label, Multi-center, Extension Study to Evaluate the Safety and Immunogenicity of a Revaccination Dose of the RSVPreF3 Older Adults (OA) Investigational Vaccine Administered Intramuscularly 18 Months Post-Dose 2 in Adults 60 Years and Older Who Participated in the RSV OA=ADJ-002 Study
Enrollment Status: Completed
Publish Date: June 29, 2022
Intervention Type: Biological
Study Drug: RSVPreF3 OA investigational vaccine
Study Phase: Phase 2
View 1 Less Clinical Trial

202 Total Publications

Skin-to-skin household transmission of mpox from parental wrist lesion to child's gluteal region.
Skin-to-skin household transmission of mpox from parental wrist lesion to child's gluteal region.
Journal: BMJ case reports
Published: August 17, 2026

Frequently Asked Questions about Marc Van Ranst

Is Marc Van Ranst a top-rated expert for Hantavirus Pulmonary Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Marc Van Ranst is classified as an Distinguished expert for Hantavirus Pulmonary Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Marc Van Ranst participate in research or clinical trials?

Yes. Marc Van Ranst has published 202 articles and abstracts on conditions like Hantavirus Pulmonary Syndrome. You can view a list of Marc Van Ranst's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Van Ranst's expertise for a condition
ConditionClose
    View All 40 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile